Trial
NCT06762808
Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
M.D. Anderson Cancer Center
Collaborators
Genentech, Inc.; Strategic Alliance
Condition
Squamous Cell Carcinoma
Intervention
Atezolizumab
Why stopped
0 participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-15